~~Jane Pepino, chair of the Ontario Women's Health Council, called it
"a good first step but Plan B must end up in front of the counter. We
wanted women to have access to it without the kind of demeaning and
intrusive questions such as the ones that had been asked.~~
Sexual history no longer taken for morning after pill
Pharmacists agree to drop controversial form
Privacy commissioner read of screening in {The Toronto} Star
Dec. 8, 2005. 01:00 AM
ELAINE CAREY
MEDICAL REPORTER
Ontario pharmacists will be asked to stop collecting sensitive
information about a woman's sexual activity before they dispense the
so-called morning after pill.
The Ontario College of Pharmacists agreed yesterday to advise
pharmacists not to use a controversial screening form to collect the
information after privacy commissioner Ann Cavoukian complained
following a report in the Toronto Star last week.
The form, which pharmacists gave women to fill out, asked for their
name, address, phone number, the date and time they last had
unprotected sex, the number of times they had unprotected sex since
their last menstrual period and what form of birth control they used.
Pharmacists stored the information in their computers.
Cavoukian said in an interview she was unaware of the form until she
read about it in the Star and "I was taken aback. It struck me that a
lot of information that was being collected was very personal. It
looked excessive and I was alarmed."
The Ontario Personal Health Information Act specifies that no personal
identifiable data be collected and "if you must collect it, you collect
the absolute minimum," she said. "It's a fundamental principle in
privacy.
"You can ask questions but you don't record it," she said. "You don't
need those things."
The form was part of voluntary guidelines issued by the Canadian
Pharmacists Association last April when the emergency contraceptive
levonorgestrel, or Plan B, was moved from a prescription drug to a
behind-the-counter or schedule 2 drug.
If the pharmacists' association had consulted with any Canadian privacy
commissioners, "we would immediately have raised these concerns," she
said. "I'm sure all the other provinces will be reviewing this."
Abby Lippman, chair of the Canadian Women's Health Council, which is
lobbying to have the pill made an over-the-counter drug so it can be
made even more widely available to women, said she was delighted by the
news.
"So long as Plan B is a schedule 2 drug we want to make sure there are
no further hurdles in the way of getting it," she said in an interview.
Jane Pepino, chair of the Ontario Women's Health Council, called it "a
good first step but Plan B must end up in front of the counter. We
wanted women to have access to it without the kind of demeaning and
intrusive questions such as the ones that had been asked. Thankfully,
pharmacists have acceded to the request."
Representatives of the Ontario Pharmacists' Association and the Ontario
College of Pharmacists acknowledged in a statement issued by
Cavoukian's office that the screening form "should be replaced by
made-in-Ontario guidelines that comply with the requirements of health
privacy legislation in Ontario."
The two organizations agreed to form a working group with the Ontario
Privacy Commissioner's office to develop guidelines to deal with the
drug "in a privacy sensitive manner."
Deb Faltmarche, vice-president of policy for the pharmacists'
association, said the groups responded quickly to the privacy
commissioner's concerns and "we will be working quickly on an Ontario
solution to a concern that has been raised.
"But pharmacists deal with privacy issues every day," she said. "This
isn't any different than any other over the counter or prescription
drug."
Cavoukian said the response of the two organizations "has been very
positive. I said `Let's work together but I don't want another
collection tool being developed.' I don't want individuals feeling they
have to provide all this information in order to get the drug."
> This is the form the Canadian Pharmacist's Association members ask
> women to fill out as part of "counselling" women who want the
> morning-after pill. The counselling fee is about $20.
What percentage of the price of Plan B in Canada is this extra twenty
dollars? Is it going to be directly out of the woman's pocket or will the
health care system pay for it?
fresh~horses - 08 Dec 2005 23:15 GMT
> > This is the form the Canadian Pharmacist's Association members ask
> > women to fill out as part of "counselling" women who want the
[quoted text clipped - 3 lines]
> dollars? Is it going to be directly out of the woman's pocket or will the
> health care system pay for it?
Since it's OTC it's not covered, just like condoms, for example.
Prescription is another matter.
If the woman chooses to see her physician and get a prescription then
it might be covered under supplemental insurance, if she has it, but
not the "universal basic". However her particular (private)
supplemental insurance may not cover this drug.
Cost for Plan B and counselling fee can vary by pharmacy. And
apparently, pharmacists *in my province* can also choose whether or not
they will do the counselling, referred to as educating by the
pharmacist I spoke to. "Pharmacists aren't really paid for educating.
We're paid for selling."
This pharmacist said she charges $30 for Plan B with a counselling fee
of $20. Each pharmacy will set their own fees, even within a chain, or
franchise. I believe one of the stories I linked gave much higher
prices in another province.
The desist counselling order applies only to Ontario. Pharmacists here
are asking these questions, and using the form linked within the CMAJ
article.